Background of the Study
Genomic variants, including single nucleotide polymorphisms (SNPs) and insertions/deletions (indels), are critical in determining individual susceptibility to diseases and drug responses. At Adamawa State University, Mubi, researchers are evaluating AI-based approaches to improve the analysis of these genomic variants. This study harnesses deep learning techniques, such as convolutional neural networks and recurrent neural networks, to enhance the detection, classification, and interpretation of genomic variants from high-throughput sequencing data (Ibrahim, 2023). The AI models are designed to reduce noise and improve sensitivity compared to traditional variant-calling algorithms. Furthermore, the integration of functional annotation tools and external genomic databases enables comprehensive interpretation of variants, distinguishing pathogenic mutations from benign polymorphisms (Chukwu, 2024). The interdisciplinary collaboration between computational biologists, geneticists, and clinicians ensures that the analytical methods are both technically robust and clinically applicable. Cloud-based platforms support the scalability of the AI system, allowing for real-time processing and analysis of large genomic datasets. This innovative approach is expected to accelerate the discovery of genetic markers for disease and facilitate personalized medicine initiatives. By automating variant analysis, the AI-based system reduces human error and provides reproducible, high-accuracy results, contributing to more effective diagnostic and therapeutic strategies (Adebayo, 2023).
Statement of the Problem
Despite the vast amount of genomic data generated by modern sequencing technologies, accurately identifying and classifying genomic variants remains challenging. At Adamawa State University, conventional variant-calling methods often exhibit high error rates, particularly in distinguishing rare pathogenic variants from common benign polymorphisms (Bello, 2023). Traditional approaches are limited by their reliance on fixed algorithms that cannot adapt to the complexity of genomic data, leading to inconsistent and unreliable results. The absence of integrated AI-based solutions further exacerbates these issues, as existing tools do not fully leverage machine learning to improve variant detection accuracy and processing speed. Moreover, the integration of external annotation databases is often fragmented, hindering comprehensive variant interpretation. These challenges delay the translation of genomic findings into clinical practice, impacting diagnostic precision and personalized treatment strategies. This study aims to address these limitations by implementing and evaluating AI-based approaches that optimize variant calling and annotation. By leveraging deep learning models and cloud computing, the proposed system will provide a more accurate and efficient pipeline for genomic variant analysis. Overcoming these obstacles is critical for advancing precision medicine and improving patient outcomes through early detection of disease-associated genetic mutations (Okafor, 2024).
Objectives of the Study
To implement AI-based models for detecting and classifying genomic variants.
To integrate external genomic databases for comprehensive variant annotation.
To evaluate the accuracy and efficiency of the AI-based approach compared to traditional methods.
Research Questions
How do AI-based methods improve the detection accuracy of genomic variants?
What impact does the integration of external annotation databases have on variant classification?
How does the AI-based approach compare with traditional methods in processing speed and error reduction?
Significance of the Study
This study is significant as it demonstrates the potential of AI to revolutionize genomic variant analysis, leading to more accurate diagnostics and personalized treatments. By enhancing detection accuracy and reducing error rates, the proposed system will support clinical decision-making and advance precision medicine initiatives (Ibrahim, 2023).
Scope and Limitations of the Study
The study is limited to the evaluation of AI-based genomic variant analysis at Adamawa State University, focusing solely on sequencing data without extending to experimental validations.
Definitions of Terms
Genomic Variant: A variation in the DNA sequence among individuals.
Deep Learning: A branch of machine learning using multi-layer neural networks to model complex patterns.
Variant Calling: The computational process of identifying genetic variations from sequencing data.
Background of the Study
Stigma and discrimination against HIV-positive individuals remain significant b...
BACKGROUND OF STUDY
Medical diagnosis, (often simply termed diagnosis) refers both to the process of attempting to determine or identifyi...
ABSTRACT
There is a growing interest about the impact of the physical environment on the recovery process of patients among health care p...
Background of the Study
River tourism, which involves recreational and commercial activities centered around rivers, has...
Background of the Study
The rapid evolution of digital technologies has transformed talent acquisition processes across industries, parti...
The title of this project is communication as a tool for enhancing organizational performance. The aim...
Background of the Study
The coordinated implementation of fiscal and monetary policies is essential for a...
Background of the study
Maternal healthcare is a critical aspect of public health, as it directly impacts the survival and...
ABSTRACT
Nigeria has a land area of 923,768.64 square kilometers, with a coastline of over 823 kilometres and navigable inland waterways...
ABSTRACT
The study is designed to investigate the impact of performance appraisal on employee motivation, for an organiz...